Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform (communications medicine, 2024)

(untitled) - Costello, RE; Waller, KMJ; Smith, R; Mells, GF; Wong, AYS; Schultze, A; Mahalingasivam, V; Herrett, E; Zheng, B; Lin, L; MacKenna, B; Mehrkar, A; et al.